Literature DB >> 14063049

MULTIPLE SCLEROSIS: THERAPEUTIC TRIALS OF CHLOROQUINE, SOLUBLE ASPIRIN, AND GAMMAGLOBULIN.

H G MILLER, J B FOSTER, D J NEWELL, D D BARWICK, R A BREWIS.   

Abstract

Entities:  

Keywords:  ASPIRIN; CHLOROQUINE; GAMMA GLOBULIN; MULTIPLE SCLEROSIS

Mesh：

Substances：

Year:  1963        PMID： 14063049      PMCID： PMC1873514          DOI： 10.1136/bmj.2.5370.1436

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  5 in total

1.  Multiple sclerosis. A trial of treatment with tolbutamide.

Authors:  J B FOSTER; H MILLER; D J NEWELL; L J KINLEN
Journal:  Lancet       Date:  1961-04-29       Impact factor: 79.321

2.  Multiple sclerosis. Trials of maintenance treatment with prednisolone and soluble aspirin.

Authors:  H MILLER; D J NEWELL; A RIDLEY
Journal:  Lancet       Date:  1961-01-21       Impact factor: 79.321

3.  Therapeutic trials in multiple sclerosis. Preliminary report on effects of intrathecal infection of tuberculin (P.P.D.).

Authors:  H MILLER; D J NEWELL; A RIDLEY; K SCHAPIRA
Journal:  J Neurol Neurosurg Psychiatry       Date:  1961-05       Impact factor: 10.154

4.  Retinopathy following chloroquine therapy.

Authors:  H E HOBBS; A SORSBY; A FREEDMAN
Journal:  Lancet       Date:  1959-10-03       Impact factor: 79.321

5.  Prognosis and treatment of multiple sclerosis-quantitative nosometric study.

Authors:  L ALEXANDER; A W BERKELEY; A M ALEXANDER
Journal:  J Am Med Assoc       Date:  1958-04-19
  5 in total
  4 in total

1.  Chloroquine inhibits HMGB1 inflammatory signaling and protects mice from lethal sepsis.

Authors:  Minghua Yang; Lizhi Cao; Min Xie; Yan Yu; Rui Kang; Liangchun Yang; Mingyi Zhao; Daolin Tang
Journal:  Biochem Pharmacol       Date:  2013-05-22       Impact factor: 5.858

Review 2.  Promotion of remyelination by polyclonal immunoglobulin in Theiler's virus-induced demyelination and in multiple sclerosis.

Authors:  B G van Engelen; D J Miller; K D Pavelko; O R Hommes; M Rodriguez
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-11       Impact factor: 10.154

3.  Deficiency of autophagy in dendritic cells protects against experimental autoimmune encephalomyelitis.

Authors:  Abhisek Bhattacharya; Xyanthine Parillon; Shenyan Zeng; Shuhua Han; N Tony Eissa
Journal:  J Biol Chem       Date:  2014-07-30       Impact factor: 5.157

Review 4.  Aspirin and multiple sclerosis.

Authors:  Sheila Tsau; Mitchell R Emerson; Sharon G Lynch; Steven M LeVine
Journal:  BMC Med       Date:  2015-06-29       Impact factor: 8.775
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.